The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 26, 2024

Filed:

Dec. 29, 2020
Applicants:

President and Fellows of Harvard College, Cambridge, MA (US);

The General Hospital Corporation, Boston, MA (US);

The Children's Medical Center Corporation, Boston, MA (US);

Inventors:

David T. Scadden, Weston, MA (US);

Rahul Palchaudhuri, Cambridge, MA (US);

Derrick J. Rossi, Newton, MA (US);

Agnieszka D. Czechowicz, Boston, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 35/14 (2015.01); A61K 35/28 (2015.01); A61K 38/16 (2006.01); A61K 47/68 (2017.01); C07K 4/04 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 35/28 (2013.01); A61K 38/164 (2013.01); A61K 38/168 (2013.01); A61K 47/6825 (2017.08); A61K 47/6849 (2017.08); A61K 47/6898 (2017.08); C07K 4/04 (2013.01); C07K 16/289 (2013.01); G01N 33/50 (2013.01); G01N 33/56966 (2013.01); G01N 33/57407 (2013.01); G01N 33/57434 (2013.01);
Abstract

Disclosed herein are non-myeloablative antibody-toxin conjugates and compositions that target cell surface markers, such as the CD34, CD45 or CD117 receptors, and related methods of their use to effectively conditioning a subject's tissues (e.g., bone marrow tissue) prior to engraftment or transplant. The compositions and methods disclosed herein may be used to condition a subject's tissues in advance of, for example, hematopoietic stem cell transplant and advantageously such compositions and methods do not cause the toxicities that are commonly associated with traditional conditioning methods.


Find Patent Forward Citations

Loading…